Clinical Trial Update: Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes a Phase 1/Phase 2 study of precision cell immunotherapy combined with transarterial chemoembolization (TACE) for advanced hepa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Precision Cells

Snippet

Sponsor: Shanghai International Medical Center | Conditions: Precision Cells, Chemotherapy | Phase 1, Phase 2 | Status: UNKNOWN